Abstract 90 Table 1

Demographics and outcomes between the 4 groups

No steroids
(n=55)
Hydrocortisone
(n=31)
Dexamethasone
(n=11)
Combined
(n=30)
P-value
Gestational age (weeks)* 28 (27, 30) 25 (24, 27) 26 (25, 27) 25 (24, 26) <0.001
Birth weight (grams)* 925 (808, 1030) 665 (555, 830) 755 (615, 1090) 640 (545, 780) <0.001
Male sex, n (%) 24 (44) 16 (52) 5 (45) 21 (70) 0.13
Antenatal steroids, n (%) 52 (95) 28 (93) 10 (91) 28 (97) 0.87
Bronchopulmonary dysplasia, n (%) 25 (45) 26 (84) 11 (100) 30 (100) <0.001
Intracranial hemorrhage, n (%) 20 (36) 22 (71) 8 (73) 26 (87) <0.001
Severe retinopathy needing intervention, n (%) 0 8 (26) 1 (9) 16 (53) <0.001
Brain volume (mm3) 315 (295, 338) 316 (301.5, 352) 330 (279, 345) 311 (279, 376) 0.88
Postmenstrual age MRI obtained (weeks)* 37 (36, 38) 38 (37, 39) 39 (37, 42) 39 (37, 41) 0.02
  • *Median (25th, 75th percentile)